We are live on ! Find out more
ACIU icon

AC Immune
ACIU

36 hedge funds and large institutions have $93M invested in AC Immune in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more capital inflows, than outflows

Capital inflows: $14.2M | Capital outflows: $10.5M

1.07% more ownership

Funds ownership: 26.75% → 27.81% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 40 → 36 (-4)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
36
Holders Change
-4
Holders Change %
-10%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
11
Reduced
13
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BVF Inc
BVF Inc
California
+$7.92M
2
Prosight Management
Prosight Management
Texas
+$3.67M
3
Renaissance Technologies
Renaissance Technologies
New York
+$708K
4
Wells Fargo
Wells Fargo
California
+$467K
5
PC
PA Capital
Virginia
+$409K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.89M
2
Artisan Partners
Artisan Partners
Wisconsin
-$1.24M
3
Boothbay Fund Management
Boothbay Fund Management
New York
-$620K
4
Millennium Management
Millennium Management
New York
-$553K
5
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
-$294K

ACIU Hedge Fund Activity: Q3 2019 in Review

36 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2019, worth a combined $93M — down 7.3% from $100M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ACIU and 3 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 11 added.

The largest buyer was BVF Inc, adding an estimated $7.92M. The largest seller was Fidelity Investments, cutting an estimated $6.89M.

  • 36 institutional investors held AC Immune (ACIU) as of Q3 2019, down from 40 in Q2 2019.
  • Funds reported $93M of AC Immune stock for Q3 2019, down 7.3% quarter-over-quarter.
  • 3 funds opened new AC Immune positions in Q3 2019 and 7 closed out, a net change of -4 holders.
  • The largest AC Immune buyer in Q3 2019 was BVF Inc, an estimated $7.92M added.
  • The largest AC Immune seller in Q3 2019 was Fidelity Investments, an estimated $6.89M sold.

Based on aggregated 13F filings for Q3 2019.